Insiders · Profile

DUNN JOHN MICHAEL

General Counsel and Secretary at IMMUNIC · EVP, New Ventures at Biogen. Filing since 31 Oct 2006. CIK 0001238648

Company
Date
Role
Action
Shares
Amount
Of holding
14 Jun 2017
General Counsel and Secretary
Bought
2,500
$7.72K
26.6%
26 Oct 2015
General Counsel and Secretary
Bought
2,000
$14.00K
27.1%
23 Oct 2015
General Counsel and Secretary
Bought
7,385
$49.93K
opened
19 Feb 2009
EVP, New Ventures
Sold, plan not stated
3,208
$163.30K
14.6%
11 Feb 2009
EVP, New Ventures
Sold, plan not stated
2,258
$114.73K
8.3%
22 Jul 2008
EVP, New Ventures
Sold, plan not stated
6,485
$463.68K
20.6%
21 Jul 2008
EVP, New Ventures
Sold, plan not stated
6,485
$437.74K
20.6%
14 Apr 2008
EVP, New Ventures
Sold, plan not stated
3,212
$206.20K
12.1%
12 Feb 2008
EVP, New Ventures
Sold, plan not stated
2,267
$138.20K
12.6%
25 Jul 2007
EVP, New Ventures
Sold, plan not stated
20,000
$1.16M
53.2%
27 Jun 2007
EVP, New Ventures
Sold, plan not stated
15,352
$812.12K
46.5%
23 Apr 2007
EVP, New Ventures
Sold, plan not stated
18,760
$917.36K
51.6%
20 Apr 2007
EVP, New Ventures
Sold, plan not stated
7,519
$346.00K
26.0%
13 Feb 2007
EVP, New Ventures
Sold, plan not stated
2,334
$114.87K
8.9%
15 Nov 2006
EVP, New Ventures
Sold, plan not stated
7,850
$384.65K
23.1%
31 Oct 2006
EVP, New Ventures
Sold, plan not stated
13,104
$613.12K
33.4%
16 decisions on file.